FYR Bio Secures $8 Million Funding Round to Expand Oncology Portfolio and Focus on Neuro-Oncology and Neurodegeneration

FYR Bio secures $8 million funding with new investors for expansion in oncology and increased emphasis on neuroscience. Recent progress in brain cancer and neurodegeneration highlights FYR's commitment to advancing disease observation and treatment response assessment.